Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy

Circulation

Volumn 107, Issue 10, 2003, Pages 1390-1395

  Geier, Christian ^a,b   Perrot, Andreas ^a   Özcelik, Cemil ^a   Binner, Priska ^c   Counsell, Damian ^d   Hoffmann, Katrin ^a,b   Pilz, Bernhard ^a   Martiniak, Yvonne ^a   Gehmlich, Katja ^e   Van der Ven, Peter F M ^e   Fürst, Dieter O ^e   Vornwald, Arnold ^f   Von Hodenberg, Eberhard ^g   Nürnberg, Peter ^a,b   Scheffold, Thomas ^c   Dietz, Rainer ^a   Osterziel, Karl Josef ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d MRC Hum Genome Map Proj Rsrc C   (United Kingdom)

^e UNIVERSITY OF POTSDAM   (Germany)

^f DRK Blutspendedienst Berlin   (Germany)

^g Herzzentrum Lahr/Baden   (Germany)

Author keywords

Cardiomyopathy; Genes; Hypertrophy

Indexed keywords

ALPHA ACTIN; CYSTEINE DERIVATIVE; LIM PROTEIN; MUSCLE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; HEREDITY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION;

ACTININ; ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; CARDIOMYOPATHY, HYPERTROPHIC; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTATION, MISSENSE; PEDIGREE; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

EID: 0037453074     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000056522.82563.5F     Document Type: Article

References (19)

1. Arber S, Halder G, Caroni P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell. 1994;79:221-231.
2. Flick MJ, Konieczny SF. The muscle regulatory and structural protein MLP is a cytoskeletal binding partner of βI-spectrin. J Cell Sci. 2000; 113:1553-1564.
3. Arber S, Hunter JJ, Ross J Jr, et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 1997;88:393-403.
4. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2001;33:655-670.
5. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104:557-567.
6. McKenna WJ, Spirito P, Desnos M, et al. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart. 1997;77:130-132.
7. Nagueh SF, Lakkis NM, Middleton KJ, et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999;99:254-261.
8. Nagueh SF, Bachinski LL, Meyer D, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001;104:128-130.
9. Sohn D-W. Chai I-H, Lee D-J, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997;30:474-480.
10. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) developed in collaboration with the American Society of Echocardiography. Circulation. 1997;95:1686-1744.
11. Vriend G. WHAT IF: a molecular modeling and drug design program. J Mol Graph. 1990;8:52-56.
12. Yao X, Perez-Alvarado GC, Louis HA, et al. Solution structure of the chicken cysteine-rich protein, CRP1, a double-LIM protein implicated in muscle differentiation. Biochemistry. 1999;38:5701-5713.
13. Kraulis PJ. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr. 1991;24:946-950.
14. Merritt EA, Bacon DJ. Raster3D: photorealistic molecular graphics. Methods Enzymol. 1997;277:505-524.
15. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18:2714-2723.
16. Young P, Gautel M. The interaction of titin and α-actinin is controlled by a phospholipid-regulated intramolecular pseudoligand mechanism. EMBO J. 2000;19:6331-6340.
17. Ausubel FM, Brent R, Kingston RE, et al. eds. Current Protocols in Molecular Biology. New York, NY: John Wiley & Sons Inc; 1987.
18. Vojtek AB, Hollenberg SM, Cooper JA. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 1993;74:205-214.
19. Agatep R, Kirkpatrick RD, Parchaliuk DL, et al. Transformation of Saccharomyces cerevisiae by the lithium acetate/single-stranded carrier DNA/polyethylene glycol (LiAc/ss-DNA/PEG) protocol. Technical Tips Online. Available at: http://tto.trends.com. 1998; protocol 01525. Accessed March 2001.